Borrelia miyamotoi: Difference between revisions
From IDWiki
Borrelia miyamotoi
Content deleted Content added
Created page with "{{DISPLAYTITLE:''Borrelia miyamotoi''}} == Background == * Tick-borne infection * Transmitted by hard-body ticks, including Vector::Ixodes scapularis (in northeastern and nortcentral North America), Vector::Ixodes pacificus (in northwestern North America), Vector::Ixodes ricinus (in Europe), Vector::Ixodes persulcatus (in Europe and Asia), and Vector::Ixodes ovatus, Vector::Ixodes nipponensis, and Vector::Ixodes pavoloskyi (in Asia) * Presen..." |
(No difference)
|
Latest revision as of 12:04, 23 July 2023
Background
- Tick-borne infection
- Transmitted by hard-body ticks, including Ixodes scapularis (in northeastern and nortcentral North America), Ixodes pacificus (in northwestern North America), Ixodes ricinus (in Europe), Ixodes persulcatus (in Europe and Asia), and Ixodes ovatus, Ixodes nipponensis, and Ixodes pavoloskyi (in Asia)
- Present worldwide, including Canada
Clinical Manifestations
- In immunocompetent patients, often causes a self-limited flu-like illness
- Can have relapses, similar to tick-borne relapsing fever
- Disease more severe in immunocompromised patients, including meningoencephalitis
Management
- Doxycycline if no neurologic involvement
- Ceftriaxone if neurologic involvement
- Also azithromycin
- Resistant to amoxicillin
Further Reading
- Borrelia miyamotoi: A Comprehensive Review. Pathogens. 2023 Feb 7;12(2):267. doi: 10.3390/pathogens12020267. PMID: 36839539; PMCID: PMC9967256.
- Human Borrelia miyamotoi Infection in North America. Pathogens. 2023 Apr 3;12(4):553. doi: 10.3390/pathogens12040553. PMID: 37111439; PMCID: PMC10145171.
